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Abstract 
The capsid protein (VP) gene of goose parvovirus (GPV) was translated into amino sequence by Editseq. The 
secondary structure and B-cell epitopes of the deduced protein were predicted by Protean. Combining the results 
according to these methods, the VP had complicated secondary structure. There were several potential B-cell epitopes 
on VP. By means of overlapping peptides expressed in Escherichia coli in combination with Western blot, B-cell 
epitopes were identified on VP. The results showed virtual linear immunodominant epitopes, which were found in 
seven fragments covering amino acid residues 35-81, 111-161, 423-453, 462-491, 531-577, 616-669, 678-732. 
 
© 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of ICESB 2011 

Keywords: goose parvovirus; capsid protein; prediction; identification; epitope 
1.Introduction 
Derzsy’s disease was described during the 1960s in Europe [1, 2]. The causative agent was identified 
as goose parvovirus (GPV). Both goose (Anser anser) and muscovy duck (Cairina moschata) are 
susceptible to this disease [3, 4]. The genome of GPV contains two major open reading frames: the first 
encoding the non-structural protein (NS) involved in viral replication and regulatory functions, and the 
second encoding three capsid proteins VP1, VP2 and VP3. The proteins VP1, VP2 and VP3 are derived 
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from the same gene, the entire amino acid sequences of VP2 and VP3 are contained within the carboxyl 
terminal portion of VP1 [5]. 
In this research, the secondary structure and B-cell epitopes of VP1 protein were predicted by Protean. 
Furthermore, we studied the localization of linear immunodominant B-cell epitopes of capsid protein of 
GPV strain H1 using viral infected sera. Identification of antigenic epitopes of the capsid protein may 
provide the basis for the development of immunity-based prophylactic, therapeutic, and diagnostic 
clinical techniques for Derzsy’s disease. 
2. Materials and methods 
2.1.Virus 
GPV H1 strain used in this study was propagated in 13-day old geese embryos and harvested from 
allantoic fluid by differential centrifugation at 8,000g for 2h and 20,000g for 1h. The virus containing 
supernatant was used for the DNA isolation. Procedures used for the DNA isolation was as described 
previously [6]. Primers Pu and Pl were prepared according a sequence of GPV strain B from a data base, 
GenBank accession no. U25749. The Pu sequence, 5ƍ CTAGAGGATCCAAAGCAGATATGTCT 3ƍ and 
the Pl sequence, 5ƍ CTTTACTCGAGTTTTTACACAGAAT 3ƍ. PCR was in 100ȝL volumes, using 10ȝL 
of 10×buffer (50 mM KC1, 100 mM Tris-Cl pH8.3, 15 mM MgCl2, 0.1% gelate), 16ȝL dNTP mixture 
(10mM), 1ȝL cDNA, 5ȝL of Pu and Pl and lȝL ExTaq polymerase (0.5u, Takara, Dalian, China). The 
PCR mixture was submitted to 30 cycles of amplification involving heating at 94ć for 1min, 54ć for 
1min, and 72ć for 3min, there was then a final extension time of 10min at 72ć. A 2ȝL aliquot of PCR 
product was visualized by agarose gel electrophoresis (2% agarose, 100 Vs for 20 min, 0.8ȝg/ml ethidium 
bromide included in gel) and subsequent U.V transillumination. The amplified VP1 gene DNA was 
inserted into the clone vector pMD18-T and sequenced. 
2.2.Serum samples 
Thirty geese from breeders that had not been vaccinated against GPV were divided randomly into two 
groups. Each group included fifteen geese. The two groups were housed in separate rooms. At 2 months 
of age, geese in the first group were infected by intraocular and intranasal inoculation of inoculation of a 
total of 0.2 ml allantoic fluid containing 105 median embryo infective dose/ml H1 strain, while geese in 
the second group were not infected. The sera collected from infected group were pooled after inoculation 
of 10 weeks and regarded as single samples for analysis. 
2.3.Prediction of secondary structure 
Nucleotide sequence of VP1 gene was translated into amino acid sequence by EditSeq, one module of 
Lasergene. The Gamier-Robson method, Chou-Fasman method and Karplus-Schulz method were used to 
predict the secondary structure of VP1 protein. 
2.4.Prediction of B-cell epitopes 
The hydrophilicity and surface probability of VP1 protein were analyzed by Kyte-Doolittle method 
and Emini method. Antigenic index was showed by Jameson-Wolf method. Finally, synthetic conclusion 
was got to evaluate the potential epitopes of VP1 protein. 
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2.5.Epitope mapping 
The resulting recombinant vector pMD18-T-VP1 was as the template to amplify the set of 19 partially 
overlapping fragments (Fig. 1a).  
 
 
Fig. 1. (a) The construction of GPV VP1 protein fragments. The VP1 protein was truncated into serial overlapping fragments 
respectively and each fragment was expressed as GST-fusion protein. The numbers at both end of each fragment represented the 
position of amino acids. VP1 protein: 1-732aa, VP2 protein: 146-732aa, VP3 protein: 199-732aa; (b) Western blot analysis of 
reactivity of VP1 truncated fusion protein. G: GST control. VP1 truncated fusion protein. 1: VP (35-100). 2: VP (81-136). 3: VP 
(124-161). 4: VP (146-198). 5: VP (423-491). 6: VP (531-595). 7: VP (616-669). 8: VP (678-732) 
The totals of 19 pairs of primers were synthesized. All the forward primers contained a BamHI 
restriction site, and reverse primers contained an XhoI restriction site and a termination codon. PCR 
products were cloned into expression vector, pGEX-6P-1 (Amersham Pharmacia Biotech, Sweden) and 
the map of these fragments confirmed by sequencing. Each fragment was expressed as glutathione S-
transferase (GST) fusion proteins in Escherichia coli Rosetta (DE3) pLysS and the recombinant proteins 
were purified by eluting from sodium dodecyl sulphate (SDS) polyacrylamide gels as described 
previously [7, 8]. Western blot procedures were also performed as previously described [8]. Anti-GST 
MoAb was used to identified the purified protein and then GPV infected geese sera was used as the 
primary antibody while horseradish peroxidase (HRP)-conjugated rabbit anti-goose antibodies were 
diluted 500-fold prior to use as secondary antibodies; the HRP substrate, 4-CN (4-Chloro-1-Napthol; 
Amresco, USA), was used for color development. Purified GST protein was included as a negative 
control.  
3.Results 
3.1.Prediction of secondary structure 
Alpha helical structure appeared at 11-20aa, 82-89aa, 194-200aa, 414-424aa according to Gamier-
Robson method and Chou-Fasman method. Beta folds were well-distributed according to these methods. 
Among the beta fold units there are several turn regions. The hydrophobicity of VP1 protein was analyzed 
by Kyte-Doolittle method. The results showed there are many hydrophilicity plots, especially 6-68aa. The 
surface probability plots of VP1 protein appeared at 26-52aa, 83-170aa, 117-124aa, 237-347aa, 505-
696aa. The probability of other regions was low. There were a lot of coil regions in VP1 protein. These 
coil regions distributed evenly. The extents of coil regions in N terminal were wider (Fig. 2). 
3.2.Prediction of B-cell epitopes 
According to Jameson-Wolf method and former results, the potential epitopes were at 20-54aa, 64-
226aa, 444-492aa, 555-596aa. Some regions showed antigenicity by Jameson-Wolf method only, but 
other indexes were lower. Such regions were questionable (Fig. 2).  
(a) (b) 
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Fig. 2. Prediction of the secondary structure and B cell epitope for VP1 protein of GPV H1 strain. A: Į helix regions; B: ȕ sheet 
regions; T: Turn regions; C: Coil regions 
3.3.Epitope mapping 
Overlapping fragments of the full-length VP1 protein were expressed. The recombinant proteins were 
purified and analyzed by SDS-PAGE and Western blot. Linear immunodominant B-cell epitopes were 
primarily found in 8 fragments: VP (35-100), VP (81-136), VP (124-161), VP (146-198), VP (423-491), 
VP (531-595), VP (616-669) and VP (678-732) (Fig. 1b), whereas other fragments were not antigenic. 
Anti-GST MAb was used to identified the purified protein (data were not shown). 
4.Discussion and conclusion 
The secondary structure of protein had great influence on epitopes. The chemical bond energy of alpha 
helical and beta fold was high. They could maintain fast higher structure of protein and could not be the 
epitopes. Meanwhile, the turn and coil regions were noncohesive structure and easily twist. The structures 
usually hovered over and displayed on the surface of protein. Therefore, antigenic indexes of these 
domains antigenic index were high [9].  
Because all the theories of predictable methods were based on protein primary structure, the 
intermolecular force was neglected. The prediction of conformational epitopes was not suitable by these 
methods. Up to now, there were no better effective ways to predict conformational epitopes. Even the 
predicted epitopes presented on the surface of protein actually, but, these epitopes could be barricaded in 
posse by the tertiary structure. 
By overlapping peptides expressed in Escherichia coli combined with Western blot, B-cell epitopes 
were identified on VP1 of GPV H1 strain. The immunogenic epitopes identified here would be expected 
to be on exposed surfaces of the GPV capsid since neutralizing antibodies generally bind to the virus 
surface to prevent virus binding to cellular receptors and viral uptake into the cell. The alignment of 
adeno-associated virus type 2 (AAV) VP1 with the GPV sequence [5] and superimposition on the canine 
parvovirus (CPV) structure [10] allows the structural location of the antigenic sites identified in this study 
to be extrapolated. The three-dimensional atomic structure of CPV has been determined [11]. The virus is 
a T=1 icosahedral structure composed of 60 subunits of VP1, VP2, and VP3 and is characterized by 
several exposed structural regions that are referred to with previously reported nomenclature [10, 11]. A 
cylinder structure protrudes from each fivefold axis and is encircled by a canyon. Each threefold axis also 
has a protruding spike formed by four loops, and each twofold axis contains a depression termed a dimple. 
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Epitopes 423-453 and 462-491 are found on the spike region, and epitope 678-732aa is located at the 
twofold dimple. 
The MAbs recognized linear epitopes of AAV2 capsid proteins efficiently precipitate monomeric and 
oligomeric capsid proteins. This indicates that the availability of the respective epitope on the capsid 
surface changes (i.e., becomes partially masked) during capsid assembly [13]. Therefore, determination of 
linear epitopes of GPV probably allowed us to identify sequences accessible on nonassembled capsid 
proteins but not accessible in the assembled capsid too. Thus, MAbs against these epitopes antibodies 
might provide useful tools for studying GPV assembly and disassembly during the infection process. 
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